ARTIA GLOBAL PARTNERS LP
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | BHVN | 80K | $1.20M |
 | ARGX | 78K | $57.76M |
 | ALEC | 71K | $210.25K |
 | RAPP | 65K | $1.92M |
 | RARE | 65K | $1.94M |
 | IONS | 60K | $3.94M |
 | NKTR | 58K | $3.30M |
 | MLYS | 57K | $2.15M |
 | VRTX | 55K | $21.58M |
 | TGTX | 55K | $1.97M |
 | SRPT | 45K | $865.22K |
 | BTSG | 42K | $1.23M |
 | KALV | 42K | $506.14K |
 | XENE | 40K | $1.61M |
 | ALNY | 35K | $15.76M |
 | IREN | 33K | $1.56M |
 | TVTX | 31K | $738.51K |
 | KNSA | 29K | $1.13M |
 | LLY | 29K | $21.90M |
 | MRNA | 24K | $614.75K |
Biohaven Ltd.
BHVN
Shares Held
80K
Value
$1.20M
argenx SE
ARGX
Shares Held
78K
Value
$57.76M
Alector, Inc.
ALEC
Shares Held
71K
Value
$210.25K
Rapport Therapeutics, Inc. Common Stock
RAPP
Shares Held
65K
Value
$1.92M
Ultragenyx Pharmaceutical Inc.
RARE
Shares Held
65K
Value
$1.94M
Ionis Pharmaceuticals, Inc.
IONS
Shares Held
60K
Value
$3.94M
Nektar Therapeutics
NKTR
Shares Held
58K
Value
$3.30M
Mineralys Therapeutics, Inc.
MLYS
Shares Held
57K
Value
$2.15M
Vertex Pharmaceuticals Incorporated
VRTX
Shares Held
55K
Value
$21.58M
TG Therapeutics, Inc.
TGTX
Shares Held
55K
Value
$1.97M
Sarepta Therapeutics, Inc.
SRPT
Shares Held
45K
Value
$865.22K
BrightSpring Health Services, Inc. Common Stock
BTSG
Shares Held
42K
Value
$1.23M
KalVista Pharmaceuticals, Inc.
KALV
Shares Held
42K
Value
$506.14K
Xenon Pharmaceuticals Inc.
XENE
Shares Held
40K
Value
$1.61M
Alnylam Pharmaceuticals, Inc.
ALNY
Shares Held
35K
Value
$15.76M
IREN Limited
IREN
Shares Held
33K
Value
$1.56M
Travere Therapeutics, Inc.
TVTX
Shares Held
31K
Value
$738.51K
Kiniksa Pharmaceuticals, Ltd.
KNSA
Shares Held
29K
Value
$1.13M
Eli Lilly and Company
LLY
Shares Held
29K
Value
$21.90M
Moderna, Inc.
MRNA
Shares Held
24K
Value
$614.75K